- Home
Industry-Supported Educational Workshops
The CRS 2025 Annual Meeting & Exposition is proud to offer Industry Supported Educational Workshops that provide attendees with unique opportunities to explore the latest advancements, technologies, and solutions in drug delivery and related sciences. These sessions are developed and presented by industry leaders and offer in-depth, application-focused education aligned with the scientific and translational goals of the Controlled Release Society. Join us to gain valuable insights, engage in hands-on learning, and connect with innovators driving the future of delivery science.
Workshop Schedule
Monday, July 14, 2025
Recent Advances in Oral Peptide Delivery – From Molecule to Market
8:00 am to 4:30 pm
Systemic delivery of peptides by the oral route is now a reality with multiple products on the market and many more in development. Attendees will learn of the latest advances in oral peptide delivery and its future directions from world leading academics and industry leaders who have successfully taken oral peptide products from preclinical development to translation into the clinic and market launch. Topics covered include fundamental mechanisms, peptide engineering, oral peptide biopharmaceutics, novel drug delivery systems and their clinical development. Insights and learnings will be shared on how to navigate the unique challenges oral peptide programs present and future directions of the field.
Goals and Objectives:
• Learn the latest developments in our understanding of oral peptide biopharmaceutics
• Hear the latest progress on the clinical development of oral products from industry leaders
• Share insights and learnings in managing the transition from preclinical to clinical development of oral peptide products
|
Sponsored by:
Oral Drug Delivery From Today to Tomorrow: Latest Innovations Best Practices
9:00 am to 4:30 pm
In this workshop there is a faculty of people with significant experience in oral drug delivery who have “been there, done that”, including the mistakes! So here is an opportunity for you to learn and discuss the challenges and opportunities for formulating, developing, and manufacturing oral dosage forms with the most recent and advanced science and technologies in mind.
The agenda covers a range of fundamental and hot topics related to oral drug delivery, with an objective to share experiences and point out where resources, expertise and, in general, help and assistance, may be found. It will be an interactive atmosphere and use real-life cases to illustrate the problems and possible solutions.
Agenda
|
Sponsored By:
|
.png) |
 |
Liquid Chromatography to Characterize and Purify your LNP Drug Product
8:00 am to 12:00 pm
The participants will learn about the advantages of using chromatography to analyze and purify LNP drug products. Specifically, the use cases on monolithic columns will be showcased. A PATfix chromatographic system with an LNP analytical platform will be installed and presented and the use of hardware and software demonstrated. Analytical methods will be shown that determine: RNA quantity and quality within LNP drug products, encapsulation efficiency, size distribution, lipid composition, RNA-lipid adducts and lipid quality. An alternative to existing purification methods for LNPs will be introduced.
|
Sponsored By:
|
.png) |
Applications of 3D Printing Technology to Accelerate Formulation of Challenging Molecules and Manufacturing
1:00 pm to 5:00 pm
This proposed workshop is to give a history and overview of 3D printing of drugs, including various technologies and applications. It will also introduce Triastek’s technology and applications as a global leader in 3D printing pharmaceuticals, as well as FDA perspective on AMT/3D printing. The objective is to demonstrate the novel 3D printing technologies and platforms for drug release and drug delivery. The workshop will demo 3D printed tablet samples.
|
Sponsored By:
|
.png) |
Diagnostics with Phospholipids - Quality Standards and Areas of Application
1:00 pm to 5:00 pm
This workshop explores the versatile applications of phospholipids in diagnostic technologies, focusing on their role in liposomal systems, molecular diagnostics, and theranostic applications. Designed for academic researchers and pharmaceutical professionals, it highlights phospholipids’ potential in assessing antimicrobial activity, ROS sensing, and photodynamic therapy. Beyond application-driven approaches, the workshop also addresses essential quality considerations and their impact on diagnostic tool development. Participants will gain insights into cutting-edge research and practical applications. The workshop concludes with an engaging panel discussion, providing an opportunity for dialogue, networking, and the exploration of future directions in this rapidly evolving field.
Learning Objectives:
• To provide an understanding of the role of phospholipids in diagnostic applications, highlighting their physicochemical properties and their influence on diagnostic performance in various contexts, such as molecular diagnostics, imaging, and theranostics.
• To inform participants about innovative uses of phospholipids in diagnostics, including liposomal systems for antimicrobial activity assays, phospholipid-coated ultrasound contrast agents, and ROSsensing liposomal hydrogels, while discussing their practical implementation and benefits.
• To engage the audience in discussions on the integration of quality considerations and application-driven research, emphasizing the advancements and challenges in leveraging phospholipids for diagnostics and their implications for clinical and research settings.
|
Sponsored By:
|
.png) |
.png)
|
Clinical development & regulatory pathways of subcutaneous formulation for biologics - An update from the Subcutaneous Drug delivery & Development Consortium
1:00 pm to 5:00 pm
The workshop aims to provide an overview of the clinical development and regulatory pathways for subcutaneous (SC) administration of biologics. The content covers the overall SC clinical development program, clinical design choices, and endpoints. It addresses the industry perspective on bridging approaches from intravenous (IV) to SC administration and associated endpoints, the impact of targeted therapy on the selection of the study population, changes between clinical phases, and the use of high- volume devices. Case study presentations will be delivered by different pharmaceutical companies. The event concludes with a panel discussion, inviting audience participation and questions.
|
Sponsored By:
|
 |
___________________________________________________
Contact Information:
Sponsorship/Funding:
Amanda Bray
Industry Relations Manager
+1.856.437.4750
abray@controlledreleasesociety.org
Workshop Application, Program/Speaker Management, Logistics:
Tara Locantore
Meeting Coordinator
+1.856.380.6879
tlocantore@controlledreleasesociety.org
General Meeting/Registration Questions:
meetings@controlledreleasesociety.org
___________________________________________________
Countdown to Philadelphia!
